Towards an individualized protocol for workload increments in cardiopulmonary exercise testing in children and

H J Hulzebos1, M S Werkman, M van Brussel

  • 1Child Development & Exercise Center, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands. H.Hulzebos@umcutrecht.nl

Insights

A new model predicts peak workload for children with cystic fibrosis (CF) during exercise tests. This individualized approach helps tailor exercise protocols for better CF patient care.

Area of Science:

  • Pediatric Exercise Physiology
  • Pulmonary Rehabilitation
  • Clinical Exercise Testing

Background:

  • Exercise testing protocols for pediatric cystic fibrosis (CF) patients lack standardization due to wide variations in age and disease severity.
  • Developing a CF-specific, individualized approach for cycle ergometry workload increments is crucial for accurate assessment.

Purpose of the Study:

  • To develop and validate a CF-specific regression model for predicting peak workload (Wpeak) in children and adolescents.
  • To establish individualized workload increments for cycle ergometry testing in CF patients.

Main Methods:

  • Utilized a database of 409 assessments from 160 pediatric CF patients, including maximal exercise data, anthropometrics, and lung function.
  • Employed backward linear regression analysis on 90% of the data to develop the predictive model for Wpeak.
  • Validated the model's predictive capacity and the protocol's time frame (10±2 minutes) in separate validation groups.

Main Results:

  • The developed regression model accurately predicted peak workload (R²=0.79), with no significant bias compared to actual measurements.
  • The model equation incorporates age, sex, height, and FEV1 to predict Wpeak.
  • Protocol validation showed that most adolescents achieved maximal effort within the target time frame.

Conclusions:

  • A novel, CF-specific linear regression model was successfully developed to predict peak workload.
  • This model enables individualized workload calculations for cycle ergometry protocols in pediatric CF patients.
  • The findings support the use of this individualized approach for optimizing exercise testing and management in CF.
Abstract

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...